Want to see JANX full AI Analyst Report?
Janx007, Janx013
Prostate Cancer, Metastatic Prostate Cancer, Castration-Resistant Prostate Cancer (Crpc), Metastatic Castration-Resistant Prostate Cancer Patients
Phase I
Recruiting
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
Sep 04, 2026
―
Janx008
Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Small Cell Lung Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Triple-Negative Breast Cancer, Squamous Cell Carcinoma Of The Head And Neck
Phase I
Recruiting
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Mar 14, 2023
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Janux Therapeutics Inc (JANX) have in its pipeline
JANX is currently developing the following drugs: Janx007, Janx013, Janx014, Janx011. These drug candidates are in various stages of clinical development as the company works toward FDA approval.